APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tenofovir Disoproxil Fumarate Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tenofovir Disoproxil Fumarate Tablets Industry Growth and Trends Forecast to 2032

28 December 2025110 pages

Choose your research edition.

Industry ResearchTenofovir Disoproxil Fumarate Tablets Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Tenofovir Disoproxil Fumarate Tablets Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Tenofovir Disoproxil Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tenofovir Disoproxil Fumarate Tablets Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tenofovir Disoproxil Fumarate Tablets Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Tenofovir Disoproxil Fumarate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tenofovir Disoproxil Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tenofovir Disoproxil Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tenofovir Disoproxil Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tenofovir Disoproxil Fumarate Tablets include Aurobindo Pharma, Gilead Sciences, GSK, Hetero Drugs, Strides Pharma, Teva Pharmaceuticals, Chengdu Beite Pharmaceutical, Haisco Pharmaceutical and Shijiazhuang Lonzeal Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tenofovir Disoproxil Fumarate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tenofovir Disoproxil Fumarate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tenofovir Disoproxil Fumarate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tenofovir Disoproxil Fumarate Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tenofovir Disoproxil Fumarate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tenofovir Disoproxil Fumarate Tablets Market by Company

Aurobindo Pharma

Gilead Sciences

GSK

Hetero Drugs

Strides Pharma

Teva Pharmaceuticals

Chengdu Beite Pharmaceutical

Haisco Pharmaceutical

Shijiazhuang Lonzeal Pharmaceuticals

Luoxin Pharmaceuticals

Qilu Pharmaceutical

Shanghai Haini Pharmaceutical

Beijing SL Pharmaceutical

Sichuan Kelun Pharmaceutical

Chongqing Yaoyou Pharmaceutical

Zhejiang Sukean Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Tenofovir Disoproxil Fumarate Tablets Segment by Type

Original Drug

Generic Drug

Tenofovir Disoproxil Fumarate Tablets Segment by Application

HIV-1 Infection

Chronic Hepatitis B

Tenofovir Disoproxil Fumarate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenofovir Disoproxil Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tenofovir Disoproxil Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenofovir Disoproxil Fumarate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tenofovir Disoproxil Fumarate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tenofovir Disoproxil Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Tenofovir Disoproxil Fumarate Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tenofovir Disoproxil Fumarate Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Tenofovir Disoproxil Fumarate Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Tenofovir Disoproxil Fumarate Tablets Industry Trends Table 25. Tenofovir Disoproxil Fumarate Tablets Industry Drivers Table 26. Tenofovir Disoproxil Fumarate Tablets Industry Opportunities and Challenges Table 27. Tenofovir Disoproxil Fumarate Tablets Industry Restraints Table 28. Global Tenofovir Disoproxil Fumarate Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Tenofovir Disoproxil Fumarate Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Tenofovir Disoproxil Fumarate Tablets Sales Share by Company (2021-2026) Table 32. Global Tenofovir Disoproxil Fumarate Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tenofovir Disoproxil Fumarate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tenofovir Disoproxil Fumarate Tablets Major Company Production Sites and Headquarters Table 35. Global Tenofovir Disoproxil Fumarate Tablets Company, Product Type & Application Table 36. Global Tenofovir Disoproxil Fumarate Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tenofovir Disoproxil Fumarate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tenofovir Disoproxil Fumarate Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Tenofovir Disoproxil Fumarate Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tenofovir Disoproxil Fumarate Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Tenofovir Disoproxil Fumarate Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Aurobindo Pharma Company Information Table 72. Aurobindo Pharma Business Overview Table 73. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 75. Aurobindo Pharma Recent Development Table 76. Gilead Sciences Company Information Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 80. Gilead Sciences Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 85. GSK Recent Development Table 86. Hetero Drugs Company Information Table 87. Hetero Drugs Business Overview Table 88. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 90. Hetero Drugs Recent Development Table 91. Strides Pharma Company Information Table 92. Strides Pharma Business Overview Table 93. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 95. Strides Pharma Recent Development Table 96. Teva Pharmaceuticals Company Information Table 97. Teva Pharmaceuticals Business Overview Table 98. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 100. Teva Pharmaceuticals Recent Development Table 101. Chengdu Beite Pharmaceutical Company Information Table 102. Chengdu Beite Pharmaceutical Business Overview Table 103. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 105. Chengdu Beite Pharmaceutical Recent Development Table 106. Haisco Pharmaceutical Company Information Table 107. Haisco Pharmaceutical Business Overview Table 108. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 110. Haisco Pharmaceutical Recent Development Table 111. Shijiazhuang Lonzeal Pharmaceuticals Company Information Table 112. Shijiazhuang Lonzeal Pharmaceuticals Business Overview Table 113. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 115. Shijiazhuang Lonzeal Pharmaceuticals Recent Development Table 116. Luoxin Pharmaceuticals Company Information Table 117. Luoxin Pharmaceuticals Business Overview Table 118. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 120. Luoxin Pharmaceuticals Recent Development Table 121. Qilu Pharmaceutical Company Information Table 122. Qilu Pharmaceutical Business Overview Table 123. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 125. Qilu Pharmaceutical Recent Development Table 126. Shanghai Haini Pharmaceutical Company Information Table 127. Shanghai Haini Pharmaceutical Business Overview Table 128. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 130. Shanghai Haini Pharmaceutical Recent Development Table 131. Beijing SL Pharmaceutical Company Information Table 132. Beijing SL Pharmaceutical Business Overview Table 133. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 135. Beijing SL Pharmaceutical Recent Development Table 136. Sichuan Kelun Pharmaceutical Company Information Table 137. Sichuan Kelun Pharmaceutical Business Overview Table 138. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 140. Sichuan Kelun Pharmaceutical Recent Development Table 141. Chongqing Yaoyou Pharmaceutical Company Information Table 142. Chongqing Yaoyou Pharmaceutical Business Overview Table 143. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 145. Chongqing Yaoyou Pharmaceutical Recent Development Table 146. Zhejiang Sukean Pharmaceutical Company Information Table 147. Zhejiang Sukean Pharmaceutical Business Overview Table 148. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 150. Zhejiang Sukean Pharmaceutical Recent Development Table 151. Chia Tai Tianqing Pharmaceutical Company Information Table 152. Chia Tai Tianqing Pharmaceutical Business Overview Table 153. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio Table 155. Chia Tai Tianqing Pharmaceutical Recent Development Table 156. North America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 158. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021-2026) Table 159. North America Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 161. North America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Tenofovir Disoproxil Fumarate Tablets Market Share by Country (2021-2026) Table 164. North America Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Tenofovir Disoproxil Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 166. Europe Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 168. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021-2026) Table 169. Europe Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Tenofovir Disoproxil Fumarate Tablets Market Share by Country (2021-2026) Table 174. Europe Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Tenofovir Disoproxil Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Share by Country (2021-2026) Table 184. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 186. Latin America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 188. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021-2026) Table 189. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Tenofovir Disoproxil Fumarate Tablets Market Share by Country (2021-2026) Table 194. Latin America Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Tenofovir Disoproxil Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Share by Country (2021-2026) Table 204. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Tenofovir Disoproxil Fumarate Tablets Distributors List Table 209. Tenofovir Disoproxil Fumarate Tablets Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Tenofovir Disoproxil Fumarate Tablets Image Figure 2. Global Tenofovir Disoproxil Fumarate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tenofovir Disoproxil Fumarate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Tenofovir Disoproxil Fumarate Tablets Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tenofovir Disoproxil Fumarate Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tenofovir Disoproxil Fumarate Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tenofovir Disoproxil Fumarate Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. HIV-1 Infection Image Figure 24. Global HIV-1 Infection Sales YoY Growth (2021-2032) & (K Units) Figure 25. Chronic Hepatitis B Image Figure 26. Global Chronic Hepatitis B Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Tenofovir Disoproxil Fumarate Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Tenofovir Disoproxil Fumarate Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Tenofovir Disoproxil Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Tenofovir Disoproxil Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Tenofovir Disoproxil Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Tenofovir Disoproxil Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Tenofovir Disoproxil Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tenofovir Disoproxil Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Tenofovir Disoproxil Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Tenofovir Disoproxil Fumarate Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Tenofovir Disoproxil Fumarate Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • HIV-1 Infection
  • Chronic Hepatitis B
Companies covered
  • Aurobindo Pharma
  • Gilead Sciences
  • GSK
  • Hetero Drugs
  • Strides Pharma
  • Teva Pharmaceuticals
  • Chengdu Beite Pharmaceutical
  • Haisco Pharmaceutical
  • Shijiazhuang Lonzeal Pharmaceuticals
  • Luoxin Pharmaceuticals
  • Qilu Pharmaceutical
  • Shanghai Haini Pharmaceutical
  • Beijing SL Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Chongqing Yaoyou Pharmaceutical
  • Zhejiang Sukean Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tenofovir Disoproxil Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tenofovir Disoproxil Fumarate Tablets Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Tenofovir Disoproxil Fumarate Tablets Market Size by Type
  9. 1.4.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tenofovir Disoproxil Fumarate Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tenofovir Disoproxil Fumarate Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tenofovir Disoproxil Fumarate Tablets Industry Trends
  2. 2.2 Tenofovir Disoproxil Fumarate Tablets Industry Drivers
  3. 2.3 Tenofovir Disoproxil Fumarate Tablets Industry Opportunities and Challenges
  4. 2.4 Tenofovir Disoproxil Fumarate Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tenofovir Disoproxil Fumarate Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Tenofovir Disoproxil Fumarate Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Tenofovir Disoproxil Fumarate Tablets Price (2021-2026)
  4. 3.4 Global Tenofovir Disoproxil Fumarate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tenofovir Disoproxil Fumarate Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Tenofovir Disoproxil Fumarate Tablets Company, Product Type & Application
  7. 3.7 Global Tenofovir Disoproxil Fumarate Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tenofovir Disoproxil Fumarate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tenofovir Disoproxil Fumarate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tenofovir Disoproxil Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Tenofovir Disoproxil Fumarate Tablets Regional Status and Outlook
  1. 4.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tenofovir Disoproxil Fumarate Tablets Historic Market Size by Region
  3. 4.2.1 Global Tenofovir Disoproxil Fumarate Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tenofovir Disoproxil Fumarate Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tenofovir Disoproxil Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tenofovir Disoproxil Fumarate Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Tenofovir Disoproxil Fumarate Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tenofovir Disoproxil Fumarate Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tenofovir Disoproxil Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tenofovir Disoproxil Fumarate Tablets by Application
  1. 5.1 Tenofovir Disoproxil Fumarate Tablets Market by Application
  2. 5.1.1 HIV-1 Infection
  3. 5.1.2 Chronic Hepatitis B
  4. 5.2 Global Tenofovir Disoproxil Fumarate Tablets Market Size by Application
  5. 5.2.1 Global Tenofovir Disoproxil Fumarate Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Tenofovir Disoproxil Fumarate Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Tenofovir Disoproxil Fumarate Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Gilead Sciences
  8. 6.2.1 Gilead Sciences Company Information
  9. 6.2.2 Gilead Sciences Business Overview
  10. 6.2.3 Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  12. 6.2.5 Gilead Sciences Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Hetero Drugs
  20. 6.4.1 Hetero Drugs Company Information
  21. 6.4.2 Hetero Drugs Business Overview
  22. 6.4.3 Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  24. 6.4.5 Hetero Drugs Recent Developments
  25. 6.5 Strides Pharma
  26. 6.5.1 Strides Pharma Company Information
  27. 6.5.2 Strides Pharma Business Overview
  28. 6.5.3 Strides Pharma Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Strides Pharma Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  30. 6.5.5 Strides Pharma Recent Developments
  31. 6.6 Teva Pharmaceuticals
  32. 6.6.1 Teva Pharmaceuticals Company Information
  33. 6.6.2 Teva Pharmaceuticals Business Overview
  34. 6.6.3 Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  36. 6.6.5 Teva Pharmaceuticals Recent Developments
  37. 6.7 Chengdu Beite Pharmaceutical
  38. 6.7.1 Chengdu Beite Pharmaceutical Company Information
  39. 6.7.2 Chengdu Beite Pharmaceutical Business Overview
  40. 6.7.3 Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  42. 6.7.5 Chengdu Beite Pharmaceutical Recent Developments
  43. 6.8 Haisco Pharmaceutical
  44. 6.8.1 Haisco Pharmaceutical Company Information
  45. 6.8.2 Haisco Pharmaceutical Business Overview
  46. 6.8.3 Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  48. 6.8.5 Haisco Pharmaceutical Recent Developments
  49. 6.9 Shijiazhuang Lonzeal Pharmaceuticals
  50. 6.9.1 Shijiazhuang Lonzeal Pharmaceuticals Company Information
  51. 6.9.2 Shijiazhuang Lonzeal Pharmaceuticals Business Overview
  52. 6.9.3 Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  54. 6.9.5 Shijiazhuang Lonzeal Pharmaceuticals Recent Developments
  55. 6.10 Luoxin Pharmaceuticals
  56. 6.10.1 Luoxin Pharmaceuticals Company Information
  57. 6.10.2 Luoxin Pharmaceuticals Business Overview
  58. 6.10.3 Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  60. 6.10.5 Luoxin Pharmaceuticals Recent Developments
  61. 6.11 Qilu Pharmaceutical
  62. 6.11.1 Qilu Pharmaceutical Company Information
  63. 6.11.2 Qilu Pharmaceutical Business Overview
  64. 6.11.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  66. 6.11.5 Qilu Pharmaceutical Recent Developments
  67. 6.12 Shanghai Haini Pharmaceutical
  68. 6.12.1 Shanghai Haini Pharmaceutical Company Information
  69. 6.12.2 Shanghai Haini Pharmaceutical Business Overview
  70. 6.12.3 Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  72. 6.12.5 Shanghai Haini Pharmaceutical Recent Developments
  73. 6.13 Beijing SL Pharmaceutical
  74. 6.13.1 Beijing SL Pharmaceutical Company Information
  75. 6.13.2 Beijing SL Pharmaceutical Business Overview
  76. 6.13.3 Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  78. 6.13.5 Beijing SL Pharmaceutical Recent Developments
  79. 6.14 Sichuan Kelun Pharmaceutical
  80. 6.14.1 Sichuan Kelun Pharmaceutical Company Information
  81. 6.14.2 Sichuan Kelun Pharmaceutical Business Overview
  82. 6.14.3 Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  84. 6.14.5 Sichuan Kelun Pharmaceutical Recent Developments
  85. 6.15 Chongqing Yaoyou Pharmaceutical
  86. 6.15.1 Chongqing Yaoyou Pharmaceutical Company Information
  87. 6.15.2 Chongqing Yaoyou Pharmaceutical Business Overview
  88. 6.15.3 Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  90. 6.15.5 Chongqing Yaoyou Pharmaceutical Recent Developments
  91. 6.16 Zhejiang Sukean Pharmaceutical
  92. 6.16.1 Zhejiang Sukean Pharmaceutical Company Information
  93. 6.16.2 Zhejiang Sukean Pharmaceutical Business Overview
  94. 6.16.3 Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  96. 6.16.5 Zhejiang Sukean Pharmaceutical Recent Developments
  97. 6.17 Chia Tai Tianqing Pharmaceutical
  98. 6.17.1 Chia Tai Tianqing Pharmaceutical Company Information
  99. 6.17.2 Chia Tai Tianqing Pharmaceutical Business Overview
  100. 6.17.3 Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product Portfolio
  102. 6.17.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Tenofovir Disoproxil Fumarate Tablets Sales by Country
  2. 7.1.1 North America Tenofovir Disoproxil Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  6. 7.2.1 North America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country
  2. 8.1.1 Europe Tenofovir Disoproxil Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  6. 8.2.1 Europe Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tenofovir Disoproxil Fumarate Tablets Sales by Country
  2. 10.1.1 South America Tenofovir Disoproxil Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  6. 10.2.1 South America Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tenofovir Disoproxil Fumarate Tablets Value Chain Analysis
  2. 12.1.1 Tenofovir Disoproxil Fumarate Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tenofovir Disoproxil Fumarate Tablets Production Mode & Process
  7. 12.2 Tenofovir Disoproxil Fumarate Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tenofovir Disoproxil Fumarate Tablets Distributors
  10. 12.2.3 Tenofovir Disoproxil Fumarate Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst